News | September 24, 2021
Amaris Clinicals clears U.S. FDA audit
The company is the Clinical Research Organisation of Caplin Point Laboratories
The company is the Clinical Research Organisation of Caplin Point Laboratories
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting
If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC
The recommendation is based on positive results from the pivotal Phase 3 CheckMate -649 trial in which Opdivo plus chemotherapy demonstrated superior overall survival versus chemotherapy
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
Subscribe To Our Newsletter & Stay Updated
